CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PROSION developed an innovative platform using chemical building blocks called ProMs to target previously undruggable proteins associated with challenging diseases. This technology aims to create small molecule drugs for conditions like cancer, Alzheimer’s, and cardiovascular diseases, enhancing treatment options for p…
Existing pharmaceutical methods can only target 15% of all proteins in the human proteome.
Given this limitation, pharmaceutical companies are running out of options to develop effective drugs to tackle hard-to-treat diseases.
To have a better chance of fighting these diseases, further targets of the remaining, so far undruggable 85% of our proteome need to be unlocked. PROSION developed a disruptive platform of chemical building blocks called ProMs.
The ProM-platform addresses a specific class…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
